[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.147.238.168. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Lab Reports
February 4, 2009

Cancer Drug Target?

JAMA. 2009;301(5):477. doi:10.1001/jama.2009.41

Scientists at the University of Utah in Salt Lake City have discovered 2 enzymes that control a form of gene regulation called DNA demethylation in vertebrates, a finding that might provide novel targets for preventing or slowing cancer growth (Rai K et al. Cell. 2008;135[7]:1201-1212).

In studies in zebrafish embryos, the researchers identified a DNA demethylation process that involves the coupling of these 2 enzymes and a nonenzymatic factor. Defects in DNA methylation, a cellular process that shuts off genes that either aren't needed or are malfunctioning, can lead to the development of cancer and other diseases.

First Page Preview View Large
First page PDF preview
First page PDF preview
×